C. Mark Schneyer

Affiliations

  • Evp, Chief Financial Officer at Acadia Pharmaceuticals Inc (ACAD), 2025-03-27
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $17.05 3,171 56,889 2025-03-26 Filing
ACAD $19.96 773 53,882 2025-02-24 Filing
ACAD $16.81 10,259 53,302 2024-11-19 Filing
ACAD $15.28 9,733 43,735 2024-08-19 Filing
ACAD $14.79 975 34,564 2024-06-10 Filing